Heverlee, Belgium

Marc De Maeyer

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Vaalbeek, BE (2014 - 2015)
  • Heverlee, BE (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Marc De Maeyer: Pioneering Antiviral Innovations

Introduction

Marc De Maeyer, a notable inventor based in Heverlee, Belgium, is recognized for his contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a remarkable portfolio that includes four patents, De Maeyer is actively engaged in advancing medical science and the treatment of viral infections.

Latest Patents

De Maeyer's recent patents showcase his innovative approach towards combating viral replication. One of his key inventions is titled "Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors." This invention details a series of compounds that demonstrate antiviral activity, specifically targeting HIV (Human Immunodeficiency Virus). The patent discusses methods for preparing these compounds, novel intermediates useful in the synthesis process, and their applications in pharmaceutical compositions designed to treat animals suffering from viral infections, particularly HIV. Another notable invention involves antiviral compounds of formula (A), again focusing on HIV replication inhibition. This patent reiterates the therapeutic potential of these compounds when combined with other antiviral drugs.

Career Highlights

Marc De Maeyer works at Katholieke Universiteit Leuven, a prestigious research institution in Belgium. His role there supports his research and development efforts in the pharmaceutical domain, particularly emphasizing his commitment to improving antiviral treatments.

Collaborations

Throughout his career, De Maeyer has collaborated with esteemed colleagues such as Patrick Chaltin and Zeger Debyser. These partnerships have likely facilitated a dynamic exchange of ideas and fostered innovation within the realm of antiviral research.

Conclusion

Marc De Maeyer's dedication to developing effective antiviral drugs demonstrates his pivotal role as an inventor in the pharmaceutical landscape. His patents not only contribute to scientific knowledge but also hold the potential to significantly impact public health by offering new avenues for treatment against viral infections like HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…